Clinical Trial Update: A Clinical Trial to Assess Pharmacokinetic/Pharmacodynamic Profiles and Safety of IVL3001 [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial evaluating pharmacokinetic/pharmacodynamic profiles and safety of IVL3001 in androgenetic alopecia has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Androgenetic Alopecia

Drugs mentioned

• IVL3001

Snippet

Sponsor: Inventage Lab., Inc. | Conditions: Androgenetic Alopecia | Phase 1, Phase 2 | Status: COMPLETED